Qualitest Recalls Effervescent Potassium Chloride Tablets Due to Labeling Error
Qualitest Pharmaceuticals is recalling 1,680 boxes of effervescent potassium chloride tablets because they may be mislabeled as a different potassium product.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a labeling mix-up. Per the rubric, minor labeling errors and voluntary precautionary recalls without reported injuries or illnesses fall under the Moderate severity level.
Plain-English summary
Qualitest Pharmaceuticals is recalling 1,680 boxes of Effervescent Potassium/Chloride Tablets, 25 meq Potassium Chloride (1865 mg), USP, Fruit Punch Flavor, 30 count. The recall is due to a labeling error where the product may be labeled as 30 count K Effervescent Tablets. The affected product is identified by Lot Number 21230-2 and has an expiration date of December 2015.
The product was distributed nationwide. It was manufactured by Tower Laboratories Ltd. for Qualitest Pharmaceuticals, Inc. The recall is classified as Class II by the FDA, indicating a situation in which there is a reasonable probability that the use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences.
Consumers should check their medication cabinets for this specific product and lot number. If found, they should stop using the product and contact their healthcare provider or pharmacist for guidance on proper disposal or replacement. This recall is precautionary regarding the labeling discrepancy.
The recalled product
- Product
- EFFERVESCENT POTASSIUM/CHLORIDE TABLETS, 25 meq Potassium Chloride (1865 mg), POTASSIUM BICARBONATE AND POTASSIUM CHLORIDE EFFERVESCENT TABLETS FOR ORAL SOLUTION, USP, FRUIT PUNCH FLAVOR, Rx only, 30 count, Manufactured for: Qualitest Pharmaceuticals, Inc., Huntsville, AL 35811
- Manufacturer
- Qualitest Pharmaceuticals
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 1,680
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot Number 21230-2
- Exp. DEC 2015
Distribution
Distribution scope not specified by the agency.
Part of a larger recall action
This product is one of 2 recalled by Qualitest Pharmaceuticals under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Qualitest Pharmaceuticals
See all →- LowQualitest Recalls Allopurinol Tablets Due to Oversized and Discolored Appearance
FDA (Drugs) · 2015-09-09
- LowQualitest Recalls HydrOXYzine Tablets Due to Unreadable Identification Codes
FDA (Drugs) · 2015-07-22
- ModerateQualitest Recalls Disulfiram Tablets Due to Dissolution Failure
FDA (Drugs) · 2015-07-08
- LowQualitest Recalls Promethazine VC With Codeine Syrup Due to Impurity
FDA (Drugs) · 2015-04-15
- ModerateQualitest Recalls Promethazine DM Syrup Due to Plastic Particulates
FDA (Drugs) · 2015-03-18
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02